Induction and inhibition of cytochrome P450-dependent monooxygenases of rats by fungicide bitertanol
The effects of fungicide bitertanol on cytochrome P450-dependent monooxygenases were studied using rats treated intraperitoneally with the N-substituted triazole for 4 days. Treatment with 10, 25, and 100 mg/kg bitertanol produced 2-, 4-, and 14-fold increases of 7-ethoxyresorufin O-deethylation act...
Gespeichert in:
Veröffentlicht in: | Food and chemical toxicology 2006-12, Vol.44 (12), p.2047-2057 |
---|---|
Hauptverfasser: | , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | The effects of fungicide bitertanol on cytochrome P450-dependent monooxygenases were studied using rats treated intraperitoneally with the
N-substituted triazole for 4 days. Treatment with 10, 25, and 100
mg/kg bitertanol produced 2-, 4-, and 14-fold increases of 7-ethoxyresorufin
O-deethylation activity in liver microsomes, respectively. Immunoblot analysis of microsomal proteins revealed that 25
mg/kg bitertanol increased CYP1A1 protein in the liver, kidney, and lung by 10-, 13-, and 17-fold, respectively. Bitertanol produced smaller increases of CYP2B and CYP3A catalytic activity and protein than that of CYP1A1 in liver. RT-PCR analysis of total RNA indicated that bitertanol-induced CYP1A1, CYP2B, and CYP3A mRNA. Additions of 0.01–100
μM bitertanol to liver microsomes from rats treated with 25
mg/kg bitertanol or 3-methylcholanthrene inhibited microsomal 7-ethoxyresorufin
O-deethylation activity (IC
50
=
0.8 or 0.9
μM). Bitertanol at 100
mg/kg increased liver UDP-glucuronosyltransferase and glutathione
S-transferase activities by 2-fold. Bitertanol at 25
mg/kg produced a minor increase in metabolic activation of benzo[
a]pyrene by liver S-9 fraction in the Ames mutagenicity test while the increase was blocked by addition of 100
μM bitertanol. These findings show that bitertanol is an inducer of CYP1A1, CYP2B, and CYP3A
in vivo and an inhibitor of CYP1A catalytic activity
in vitro. |
---|---|
ISSN: | 0278-6915 1873-6351 |
DOI: | 10.1016/j.fct.2006.07.005 |